Emedgene Company
Emedgene provides data-driven AI solutions for genomic diagnostics and discovery at scale.
Investors Number:
3.0
Total Funding:
6000000.0
Technology:
['BioTech & HealthTech']
Estimated Revenue:
$1M to $10M
Employee Number:
11-50
Investment Stage:
N/A
Industry:
Health Tech
Founded Date:
2015-01-01
Headquarters:
Palo Alto, California, United States
Number Of Exists:
N/A
Last Funding Date:
2019-02-19
Last Funding Type:
Series A
Investor Type:
info@emedgene.com
Funding Status:
Early Stage Venture